Jensen Investment Management MRK trades
Eric H. Schoenstein
Eric H. Schoenstein Merck & Company Inc stake
total: 257
Trades details
- Total transactions:
- 7
- New positions:
- 3
- Sold out:
- 3
- Reduced:
- 1
- Held since:
- 2016 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2016 Q3
According to 2026 Q2 report, Eric H. Schoenstein doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $52.93 for "buy" trades and estimated average "sell" price is $57.67. Jensen Investment Management first purchased MRK in 2015 Q1, initially acquiring 9,530 shares. Eric H. Schoenstein later completely sold out the position and invested in Merck & Company Inc again in 2016 Q1. Since the initial investment in Merck & Company Inc (MRK), Jensen Investment Management has made 6 more transactions.
When did Eric H. Schoenstein sell Merck & Company Inc (MRK)?
Eric H. Schoenstein sold off the entire Merck & Company Inc (MRK) position in 2016 Q3.
When did Eric H. Schoenstein buy Merck & Company Inc (MRK)?
Eric H. Schoenstein first invested in Merck & Company Inc (MRK) in 2015 Q1 at the reported quarter-end price of $57.50 per share.
What's the cost basis of Jensen Investment Management's MRK stake?
The estimated cost basis for Merck & Company Inc (MRK) stake is around $52.93 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $52.93
- Weighted AVG sell price:
- $57.67
Eric H. Schoenstein's historical trades in Merck & Company Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2016 Q3
|
0.00%
|
$57.67
|
-100% (-7,560)
|
|||
|
2016 Q2
|
0.01%
|
$57.67
|
-3.82% (-300)
|
|||
|
2016 Q1
|
0.01%
|
$52.93
|
new
|
|||
|
2015 Q4
|
0.00%
|
$49.39
|
-100% (-7,370)
|
|||
|
2015 Q3
|
0.01%
|
$49.39
|
new
|
|||
|
2015 Q2
|
0.00%
|
$57.50
|
-100% (-9,530)
|
|||
|
2015 Q1
|
0.01%
|
$57.50
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.